GGrantIndex
Sort

39,280 grants matching leukemia

Regulation of Apoptosis by Bcl-xL and other factors

$358,750
J. Marie Hardwick · Johns Hopkins University · R01 · FY2010 · NS

Notch signaling in brain tumors

$358,750
Charles George Eberhart · Johns Hopkins University · R01 · FY2008 · NS

ADMINISTRATION

$358,712
Marcy A List · University Of Chicago · P30 · FY2009 · CA

CHILDRENS CANCER GROUP

$358,698
Children'S Hospital Los Angeles · U10 · FY2002 · CA

Studies of other risk factors for radiosensitive tumors

$358,696
Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

JAK/STAT signaling in the pathogenesis of DNMT3A mutant T-ALL

$358,691
Grant Anthony Challen · Washington University · R01 · FY2023 · CA

JAK/STAT signaling in the pathogenesis of DNMT3A mutant T-ALL

$358,691
Grant Anthony Challen · Washington University · R01 · FY2022 · CA

Estimating the Cost Trajectories and Projecting the Cost of Cancer Care in the United States: Methodology and Application

$358,680
Liang Li · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Cytokine Regulation of Photoreceptor Gene Expression

$358,620
John D. Ash · University Of Florida · R01 · FY2016 · EY

t(8;21) and SON in Blood Cell Proliferation and Differentiation

$358,571
Dong-Er Zhang · University Of California, San Diego · R01 · FY2012 · CA

t(8;21) and SON in Blood Cell Proliferation and Differentiation

$358,571
Dong-Er Zhang · University Of California, San Diego · R01 · FY2011 · CA

Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL

$358,566
Michael W Deininger · Versiti Wisconsin, Inc. · R01 · FY2024 · CA

Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia

$358,565
Michael W Deininger · Versiti Wisconsin, Inc. · R01 · FY2024 · CA

Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML

$358,560
Hong-Yu Li · Univ Of Arkansas For Med Scis · R01 · FY2018 · CA

Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML

$358,560
Hong-Yu Li · Univ Of Arkansas For Med Scis · R01 · FY2017 · CA

DEREGULATION OF CELLULAR IKB KINASES BY HTLV1 TAX

$358,519
Vanderbilt University · R01 · FY2000 · CA

Glial Cell Inflammatory Mechanisms and CNS Regulation

$358,502
Janice Ellen Clements · Johns Hopkins University · R01 · FY2007 · NS

Characterization of Neuronal Differentiation by Adult CNS Progenitors

$358,502
Hongjun Song · Johns Hopkins University · R01 · FY2007 · NS

Glial Cell Inflammatory Mechanisms and CNS Regulation

$358,502
Janice Ellen Clements · Johns Hopkins University · R01 · FY2008 · NS

Targeting the GFI1-LSD1 Axis in T-Cell Acute Lymphoblastic Leukemia

$358,348
Michael E Engel · University Of Virginia · R01 · FY2019 · CA

Transcriptional Control of Gastrin

$358,334
Juanita L Merchant · University Of Michigan At Ann Arbor · R37 · FY2014 · DK

The Development of Stat3 Inhibitors

$358,327
John S McMurray · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA

The Role of NOTCH1 in the Pathogenesis of CLL.

$358,315
Riccardo Dalla-Favera · Columbia University Health Sciences · R01 · FY2013 · CA

The Role of NOTCH1 in the Pathogenesis of CLL.

$358,315
Riccardo Dalla-Favera · Columbia University Health Sciences · R01 · FY2016 · CA

The Role of NOTCH1 in the Pathogenesis of CLL.

$358,315
Riccardo Dalla-Favera · Columbia University Health Sciences · R01 · FY2017 · CA